Friday, February 17, 2023 4:35:12 PM
Once those groups are enabled and allowed to strike "backroom deals" then it is right next to game over for the people getting the things that are best for them, rather than what is best for the decision maker.
I don't think many here believe that the Revive product will not be one of the best things made available for the current situation. We all know that the drug poses no threat in terms of its safety of use. We have already heard that it is capable of treating several (many) of the symptoms of COVID and its after effects. It makes no sense that we've had to wait this long for a therapeutic that is safe and presumably effective.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM